Antithymocyte Globulin and Sirolimus in Treating Patients With Relapsed Multiple Myeloma
Status:
Completed
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Biological therapies, such as antithymocyte globulin may stimulate the immune
system in different ways and stop cancer cells from growing. Sirolimus may stop the growth of
cancer cells by blocking some of the enzymes needed for cell growth. It may also prevent or
reduce the side effects of antithymocyte globulin. Giving antithymocyte globulin together
with sirolimus may kill more cancer cells.
PURPOSE: This phase I trial is studying the side effects and best dose of antithymocyte
globulin when given together with sirolimus in treating patients with relapsed multiple
myeloma.